•
Beijing-based Genetron Holdings Ltd (NASDAQ: GTH) has officially entered into a privatization and merger agreement with a consortium comprising CICC, Wealth Strategy Holding Limited, Wuxi Guolian Development, CCB Trust (Beijing) Investment Fund Management, among others, as reported by Xinhua News Agency. The consortium will acquire Genetron’s American Depository Shares (ADSs)…
•
CStone Pharmaceuticals (HKG: 2616), a China-based biopharmaceutical company, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its “Human PDGFRA Gene D842V Mutation Detection Kit”. This companion diagnostic (CDx) kit, co-developed with Beijing-based Genetron Holdings Ltd (Nasdaq: GTH), is used for the detection…